Veterinary Stents Market - By Product, By Animal, By Application, By Material, By End Use - Global Forecast, 2025 - 2034

Veterinary Stents Market Size

The global veterinary stents market size was valued at USD 45 million in 2024. The market size is estimated to grow from USD 47.5 million in 2025 to USD 85.3 million in 2034, growing at a CAGR of 6.7% from 2025 to 2034.
 

Veterinary stents are commonly used in veterinary medicine to manage tracheal collapse, urethral obstructions, esophageal strictures, and vascular anomalies in animals. With the increasing emphasis on pets' health and well-being by their owners, there is an increased demand for advanced medical interventions, including stents. This demand is further supported by the rising number of pets, with the 2024 Global Pet Parent Study citing almost 1 billion pets worldwide. Additionally, the growing humanization of pets which makes pet owners highly interested in sophisticated pet care, further contributes to the adoption of stenting procedures, especially in developed economies with advanced veterinary care.
 

In addition, the technological advances have significantly impacted on the growth of this market. The introduction of minimally invasive techniques, newer stent materials including nitinol, polymers, and improvements in endoscopic and fluoroscopic placement techniques have resulted in increased effectiveness and widespread acceptance of veterinary stents. These innovations have resulted in better patient outcomes, less recovery times, and minimal risk of complications, making stents a preferred option for both veterinarians and pet owners.
 

Further, the consolidation of veterinary clinics and hospitals also drives the market growth significantly. Veterinary chains and corporate entities purchase independent clinics which lead to greater spending on next level diagnostic and treatment technologies like stenting, which in turn aids the growth of veterinary stents market. Furthermore, adoption of pet insurance has significantly aided in covering these costs by increasing the financial accessibility of stenting procedures to a wider population.
 

Veterinary stents are implants used on animals that suffer from obstructions or narrowing of an anatomical structure due to various diseases, traumatic injuries, or congenital malformations. These devices which are tubular in shape are constructed from metal alloys, like nitinol, or polymer-based compounds and are inserted into airways, blood vessels, and other tubular structures for normal function restoration.
 

Veterinary Stents Market Trends

• The increasing prevalence of respiratory and urological disorders in animals is one of the major key trends driving the global market.
   
• Respiratory disorders, particularly tracheal collapse, commonly affect the small dog breeds, which greatly drives the demand for tracheal stents. Tracheal collapse is a progressive chronic disease frequently affecting toy and small breed dogs like Yorkshire Terriers, Pomeranians, and Chihuahuas.
   
• Traditional treatment options such as the use of corticosteroids and bronchodilators offer temporary relief, whereas the tracheal stents help in maintaining airway patency, offering a long-term treatment option. Thus, with growing recognition as an effective alternative to invasive surgeries there is an increased adoption of tracheal stents among veterinarians and pet owners.
   
• Additionally, urinary tract obstruction is a life-threatening condition that commonly affects male cats and ruminants such as goats and cattle.
   
• For instance, as per an article published by Today’s Veterinary Practice, the feline urethral obstruction incidence was estimated between 1.5% and 9%, indicating a growing need for effective and less invasive interventions, such as urethral stenting.
   
• In livestock, the prevalence of urethral obstruction is also significant, especially in younger aged male ruminants, where studies by the Indian Council of Agricultural Research (ICAR) estimate that 60% of cases occur in such animals. Additionally, in cattle, urethral obstruction occurs in 18.69% of cases and predominantly affects male cattle.
   
• With these rising cases of urinary obstruction, there is an increased adoption of urethral stents, which serve as a minimally invasive alternative to traditional interventions such as urethrotomy or perineal urethrostomy surgery. These urethral stents reduce surgical risks as well as recovery times and restore normal urinary function, making them an ideal option in veterinary practice.
   
• Thus, as the incidence of chronic diseases including respiratory and urological disorders in both companion and livestock animals grows, the need for veterinary stents is simultaneously expected to grow over the coming years.
   
• Moreover, with advanced veterinary medicine there is an improved diagnosis and treatment of such conditions, which further drives the demand for less invasive solutions like tracheal and urethral stents.
   

Veterinary Stents Market Analysis

Based on product, the global market is segmented into airway stents, vascular stents, urethral stents, and other stents. The airway stents segment dominated the global market and was valued at USD 17.7 million in 2024.
 

• The growth of this segment is majorly driven by the rising prevalence of tracheal collapse in small dog breeds. Tracheal collapse is a chronic and progressive condition causing narrowing of airways and resulting in severe respiratory distress. Thus, the severity of this condition necessitates airway stenting.
   
• Adoption of airway stents has been facilitated by the changing pet owner and veterinarian preference toward minimally invasive veterinary procedures as well as innovation in stent materials like self-expanding nitinol and biodegradable polymers.
   
• Furthermore, the development of endoscopic and fluoroscopic-guided methods for placement has increased precision, decreased complication rates, and improved overall success rates. Owing to these advancements, airway stents have become more effective and accessible, leading to their widespread adoption in specialty veterinary hospital and emergency clinics.

Based on animal, the global veterinary stents market is categorized into dogs, cats and other animals. The dogs segment accounted for significant market share of 60.5% in 2024.
 

• The increase in cases of stent-requiring conditions in canines, such as urethral obstructions, tracheal collapse, and vascular abnormalities, contributes to the high growth of this segment.
   
• Small and toy breeds are more susceptible to tracheal collapse which require airway stenting. Similarly, large breed dogs commonly have vascular and urethral obstructions, greatly augmenting the demand for vascular and urethral stents.
   
• Due to its success and low recovery times in contrast to traditional surgery, stenting is one of the preferred treatment options. Thus, as veterinary care advances and minimally invasive procedures gain traction, the demand for veterinary stents is expected to rise in small animals particularly dogs.
   
• Additionally, the significant populations of dogs worldwide have further contributed to the dominance of the dog’s segment in the market. Approximately 30% of global households owning a dog means there are roughly between 700 million to 1 billion dogs. The U.S. is also the leader in pet dogs with 90 million, which makes them an important market for advanced veterinary stents.
   

Based on the application, the global veterinary stents market is classified into airway collapse, vascular obstructions, urinary tract obstructions, and other applications. The airway collapse segment was valued at USD 18.7 million and is poised to grow at 6.8% CAGR over the analysis period.
 

• The growth of the segment can be attributed to the increasing cases of tracheal and bronchial collapse in companion animals. Airway collapse is a progressive chronic disease of the respiratory system which results in extreme difficulty in breathing, incessant coughing, and other critical complications.
   
• With advancements in veterinary medicine, there is an increase in adoption of tracheal stenting as it is a preferred, less invasive option than surgery. It significantly lowers recovery time and other risks associated with the procedure.
   
• There has been greater adoption of nitinol self-expanding stents and biodegradable stents. Also, improved fluoroscopic and endoscopic placement techniques have enhanced clinical success rates. These factors have made airway stents an important part of veterinary medicine.
   

Based on material, the global veterinary stents market is divided into nitinol and biodegradable polymer. The nitinol segment dominated the market and is expected to grow at 6.4% CAGR over the analysis period.
 

• The market share for the nitinol segment has improved due to the unique expanding capabilities of nitinol stents, which provide flexible, excellent biocompatibility, and corrosion resistance, making it an ideal material for stents used in veterinary medicine.
   
• Stents constructed from nitinol are actively employed in the management of airway collapse, vascular blockages, and urinary tract disorders in animals, offering low-impact surgical intervention while supporting long-term structural stability and adaptability to evolving anatomic shifts.
   
• The increasing adoption of self-expanding nitinol stents in veterinary practice has greatly enhanced growth in this market segment. Self-expanding stents optimize placement within the vessel and severely reduce the possibility of movement or blockage due to scar tissue formation.
   
• In addition, increasing development of coated biodegradable nitinol stents, guided stent implantation methods, and their precise placement improve the treatment results and clinical results, thus fostering the growth of this market segment.
   

Based on end use, the global veterinary stents market is bifurcated into veterinary hospitals and clinics and other end users. The veterinary hospitals and clinics segment is expected to grow at 6.6% CAGR to reach USD 69.2 million by 2034.
 

• Veterinary hospitals and clinics are the primary points of care, providing diagnostic imaging, endoscopic operations, and minimally invasive surgeries such as stenting for correcting tracheal collapse, urethral obstruction, and esophageal stricture.
   
• Access to advanced specialty veterinary services and stenting procedures provided by 24/7 emergency hospitals has greatly improved, resulting in increased market adoption.
   
• Additionally, the growing humanization of pets and pet ownership have led to an increase in expenditure on stenting solutions and other advanced surgical care.
   
• Furthermore, increased pet insurance coverages in developed regions such as North America and Europe propels the global veterinary hospitals and clinics segment of the market, as costly procedures become widely accessible.

The North America veterinary stents market dominated the global market with a share of 41.5% in 2024. The U.S. market was valued at USD 14.7 million in 2021. In 2023, the U.S. dominated the North American market with a revenue of USD 16.1 million growing from USD 15.4 million in 2022.
 

• This growth is largely attributed to the high pet ownership levels and the well-developed veterinary care facilities existing in the country.
   
• According to the 2021–2022 National Pet Owners Survey by the American Pet Products Association (APPA), 70% of U.S. households owned at least one pet, including approximately 69 million dog-owning households, 45.3 million with cats, 9.9 million with birds, and 3.5 million with horses.
   
• This increased pet ownership has surged the demand for specialized veterinary services, which includes stenting for tracheal collapse, urethral obstructions, and vascular conditions.
   
• Moreover, the U.S. is well known for having a developed system of veterinary pet hospitals, specialized clinics, and emergency centers, many of which are equipped to perform stent placement through imaging and endoscopic techniques.
   

Germany veterinary stents market is expected to witness significant growth in the Europe market over the analysis period.
 

• As one of the largest pet markets in Europe, Germany has a significant population of pet dogs and cats, which increases the demand for specialized veterinary treatments, including stent procedures for airway collapse, urethral obstructions, and vascular anomalies.
   
• Furthermore, favorable regulatory support for animal welfare and wide adoption of pet insurance coverage, have encouraged pet owners to opt for advanced, costlier treatments to improve pet health outcomes.
   

China veterinary stents market dominates the Asia Pacific market.
 

• According to the Chinese Pet Industry Association (2023), over 60% of urban households in China now own pets, a substantial increase from 48% in 2021. This sharp rise indicates a shift in the younger demographic's attitude, as many now consider pets to be part of the family and tend to spend on their health and well-being.
   
• There is an increased patient pet population which in turn increases the demand for veterinary services that offer specialized care. These types of care include minimally invasive procedures such as stenting for tracheal collapse, urinary tract obstruction, and vascular anomalies.
   

Brazil veterinary stents market is experiencing significant growth in the Latin America market.
 

• With approximately 168 million pets, Brazil holds largest pet population in Latin America and third in the world, where dogs are the most common companion animals.
   
• The rise in humanization of pets, where pets are increasingly treated as family members, has positively impacted the increased spending on veterinary services including those requiring veterinary stents.
   
• This market is growing due to the strong focus and increasing awareness of severe conditions such as tracheal collapse, urethral obstruction, and esophageal strictures.
   

Saudi Arabia veterinary stents market is poised to witness rapid growth in the Middle East and Africa market.
 

• The country has seen a notable shift in attitudes toward pet ownership, particularly among younger generations and urban populations, where dogs and cats are becoming increasingly popular as companion animals.
   
• This shift is translating into greater demand for specialized veterinary care, including the use of stents for treating airway collapse, urinary tract obstructions, and vascular disorders in animals.
   
• In addition, the emergence of private veterinary service providers, rising disposable income, and increased awareness of companion animal health are further accelerating market growth.
   

Veterinary Stents Market Share

The market is moderately consolidated, with a combination of established companies and emerging innovators competing based on product portfolio, geographic coverage, and area of expertise. Top 3 players such as Infiniti Medical, Dextronix and TaeWoong Medical accounted for a substantial market share of  ~45% in the global market due to their extensive veterinary-specific stent portfolios. Infiniti Medical is recognized for a wide range of products including stents for trachea, urethra, and vessels, and product line alongside its commitment to clinician training and procedure support, positioning it as a leader in the segment.
 

These companies provide customized designs for issues such as airway collapse in small breed dogs, enabling them to serve niche segments that are often neglected. As the demand for minimally invasive veterinary procedures continues to grow, competitive dynamics are expected to intensify, with innovation, training, and regional expansion being the key differentiators.
 

Veterinary Stents Market Companies

Some of the prominent players operating in the veterinary stents industry include:

• AbtVet (Stening group)
• Create Medic
• Dextronix
• EpiicVet
• Infiniti Medical
• M.I. Tech
• TaeWoong Medical
• UltraVet Medical Devices
   

Create Medic is known for its high-precision urethral and urinary stents, it benefits from its strong foothold in Asia, particularly Japan, and a focus on urological innovations for both human and veterinary use.
 

Infiniti Medical has an extensive and diversified veterinary stent portfolio, including Vet Stent-Trachea, Ureter, Urethra, and Cava, and a global distribution network, widely recognized for technological innovation and training support.
 

Veterinary Stents Industry News

• In October 2024, Infiniti Medical expanded its Vet Stent Cava portfolio by introducing two new product variants with diameters of 28 mm and 30 mm. This strategic product expansion enabled the company to cater to a broader range of veterinary patients, enhancing its market presence and meeting the growing demand for size-specific stent solutions in companion animals.
   
• In November 2024, veterinarians from Linnaeus Veterinary Limited, UK, partnered with The British Veterinary Clinic in the UAE to successfully perform the country's first veterinary interventional cardiology procedures, including stenting and balloon valvuloplasty. This strategic collaboration is driving market growth by expanding access to advanced veterinary procedures in emerging regions and boosting demand for specialized stenting solutions.
   

The veterinary stents market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Airway stents
• Vascular stents
• Urethral stents
• Other stents

Market, By Animal

• Dogs
• Cats
• Other animals

Market, By Application

• Airway collapse
• Vascular obstructions
• Urinary tract obstructions
• Other applications

Market, By Material

• Nitinol
• Biodegradable polymer

Market, By End Use

• Veterinary hospitals and clinics
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE